A recent study found that the drug tranexamic acid has minimal impact in controlling blood loss in severely injured trauma patients at the standard doses given, according to researchers at Washington ...

Administering tranexamic acid (TxA), a drug used to reduce bleeding during heart surgery, topically rather than intravenously did not meet its primary endpoint of reducing seizures and was stopped ...

Topical and intravenous tranexamic acid (TXA) were found to significantly reduce blood loss compared with placebo in patients who have undergone bone surgery, suggesting that both administration ...

Rx Bandz has developed a novel drug delivery platform for emergency injectable drugs Rx Bandz is creating a new auto-injector and a reformulation of TXA to treat non-compressible hemorrhages on the ...

Interim results of a study conducted by researchers at Hospital for Special Surgery (HSS) suggest that oral tranexamic acid (TXA) is non-inferior to intravenous (IV) TXA in preventing blood loss in ...

ORLANDO -- A hospital policy to increase the use of perioperative tranexamic acid (TXA) reduced blood transfusions during major noncardiac surgeries with no apparent impact on clotting events, a ...

LBA-5: A hospital policy of tranexamic acid to reduce transfusion in major non-cardiac surgery: The TRACTION trial ORLANDO, Fla., Dec. 9, 2025 /PRNewswire/ -- When hospitals were randomly assigned to ...

The use of adjunctive topical tranexamic acid (TXA) showed benefits in significantly reducing postoperative bleeding with second intention healing, or allowing wounds to heal naturally without sutures ...